95 related articles for article (PubMed ID: 3355560)
1. Partial purification of 2,3-oxidosqualene-lanosterol cyclase from hog-liver. Evidence for a functional thiol residue.
Duriatti A; Schuber F
Biochem Biophys Res Commun; 1988 Mar; 151(3):1378-85. PubMed ID: 3355560
[TBL] [Abstract][Full Text] [Related]
2. Purification of 2,3-oxidosqualene cyclase from rat liver.
Moore WR; Schatzman GL
J Biol Chem; 1992 Nov; 267(31):22003-6. PubMed ID: 1429550
[TBL] [Abstract][Full Text] [Related]
3. Preferential cyclization of 2,3(S):22(S),23-dioxidosqualene by mammalian 2,3-oxidosqualene-lanosterol cyclase.
Boutaud O; Dolis D; Schuber F
Biochem Biophys Res Commun; 1992 Oct; 188(2):898-904. PubMed ID: 1445330
[TBL] [Abstract][Full Text] [Related]
4. Solubilization and identification of essential functional groups of Candida albicans oxidosqualene cyclase.
Carrano L; Noe M; Grosa G; Milla P; Denaro M; Islam K
J Med Vet Mycol; 1995; 33(1):53-8. PubMed ID: 7650579
[TBL] [Abstract][Full Text] [Related]
5. Purification, tandem mass characterization, and inhibition studies of oxidosqualene-lanosterol cyclase enzyme from bovine liver.
Wu TK; Huang CY; Ko CY; Chang CH; Chen YJ; Liao HK
Arch Biochem Biophys; 2004 Jan; 421(1):42-53. PubMed ID: 14678783
[TBL] [Abstract][Full Text] [Related]
6. Effect of a supernatant protein on microsomal squalene epoxidase and 2,3-oxidosqualene-lanosterol cyclase.
Saat YA; Bloch KE
J Biol Chem; 1976 Sep; 251(17):5155-60. PubMed ID: 956181
[TBL] [Abstract][Full Text] [Related]
7. 22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase.
Viola F; Ceruti M; Balliano G; Caputo O; Cattel L
Farmaco; 1990 Sep; 45(9):965-78. PubMed ID: 2282128
[TBL] [Abstract][Full Text] [Related]
8. Some properties of the microsomal 2,3-oxidosqualene sterol cyclase.
Yamamoto S; Lin K; Bloch K
Proc Natl Acad Sci U S A; 1969 May; 63(1):110-7. PubMed ID: 5257956
[TBL] [Abstract][Full Text] [Related]
9. Purification and some properties of squalene-2,3-epoxide: lanosterol cyclase from rat liver.
Kusano M; Abe I; Sankawa U; Ebizuka Y
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):239-41. PubMed ID: 2049810
[TBL] [Abstract][Full Text] [Related]
10. Microsomal enzymes of cholesterol biosynthesis from lanosterol. Solubilization and purification of steroid 8-isomerase.
Paik YK; Billheimer JT; Magolda RL; Gaylor JL
J Biol Chem; 1986 May; 261(14):6470-7. PubMed ID: 2422166
[TBL] [Abstract][Full Text] [Related]
11. Affinity labeling of vertebrate oxidosqualene cyclases with a tritiated suicide substrate.
Abe I; Bai M; Xiao XY; Prestwich GD
Biochem Biophys Res Commun; 1992 Aug; 187(1):32-8. PubMed ID: 1520315
[TBL] [Abstract][Full Text] [Related]
12. Characterization and partial purification of squalene-2,3-oxide cyclase from Saccharomyces cerevisiae.
Balliano G; Viola F; Ceruti M; Cattel L
Arch Biochem Biophys; 1992 Feb; 293(1):122-9. PubMed ID: 1731628
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of the gene encoding 2,3-oxidosqualene-lanosterol cyclase from Saccharomyces cerevisiae.
Shi Z; Buntel CJ; Griffin JH
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7370-4. PubMed ID: 8041797
[TBL] [Abstract][Full Text] [Related]
14. N-[(1,5,9)-trimethyl-decyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol a novel potent inhibitor of 2,3-oxidosqualene cycloartenol and lanosterol cyclases.
Taton M; Benveniste P; Rahier A
Biochem Biophys Res Commun; 1986 Jul; 138(2):764-70. PubMed ID: 3741433
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.
Viola F; Brusa P; Balliano G; Ceruti M; Boutaud O; Schuber F; Cattel L
Biochem Pharmacol; 1995 Sep; 50(6):787-96. PubMed ID: 7575639
[TBL] [Abstract][Full Text] [Related]
16. Effects of a supernatant protein activator on microsomal squalene-2,3-oxide-lanosterol cyclase.
Caras IW; Bloch K
J Biol Chem; 1979 Dec; 254(23):11816-21. PubMed ID: 500676
[TBL] [Abstract][Full Text] [Related]
17. 3-Carboxy-4-nitrophenyl-dithio-1,1',2-trisnorsqualene: a site-directed inactivator of yeast oxidosqualene cyclase.
Balliano G; Grosa G; Milla P; Viola F; Cattel L
Lipids; 1993 Oct; 28(10):903-6. PubMed ID: 8246689
[TBL] [Abstract][Full Text] [Related]
18. 29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.
Ceruti M; Rocco F; Viola F; Balliano G; Milla P; Arpicco S; Cattel L
J Med Chem; 1998 Feb; 41(4):540-54. PubMed ID: 9484504
[TBL] [Abstract][Full Text] [Related]
19. Solubilization, partial purification and characterization of rat liver microsomal diacylglycerol acyltransferase.
Polokoff MA; Bell RM
Biochim Biophys Acta; 1980 Apr; 618(1):129-42. PubMed ID: 7378426
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical detergent effects on microsomal protein disulphide isomerase.
Freedman RB; Newell A; Walklin CM
FEBS Lett; 1978 Apr; 88(1):49-52. PubMed ID: 639992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
